Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

9 Biggest Mid-Day Gainers For Monday

MAN, HMNY, CYCC, EXEL, CVGW, ARRY, IPSEY

Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares jumped 105.5 percent to $2.12 amid news of merger with Zone Technologies.

Vascular Biogenics Ltd (NASDAQ: VBLT) shares rose 81.11 percent to $7.19 in pre-market trading after the company reported data that showed significant overall survivor benefit in rGBM patients receiving VB-111 versus historical Avastin.

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares climbed 65.15 percent to $7.27 after the company issued updated data from its DNA damage response program on seliciclib and sapacitabine combo in patients with solid tumors.

Command Security Corporation (NYSE: MOC) shares jumped 48.55 percent to $3.58 after the company reported that it was awarded a 10-year Indefinite Quantity Airport Security Screening Services contract with the DHS Transportation Security Administration.

Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) shares surged 23.37 percent to 4.54 after the company reported preliminary financial results for the first quarter. The company projects to report profit in the quarter.

CIBER, Inc. (NYSE: CBR) rose 19.33 percent to $1.42. ManpowerGroup Inc. (NYSE: MAN) agreed to acquire Dutch business of Ciber for $25 million in cash.

Exelixis, Inc. (NASDAQ: EXEL) rose 10.70 percent to $7.30 in pre-market trading. Exelixis and its partner Ipsen (OTC: IPSEY) reported positive positive overall survival results from subgroup analyses of Phase 3 trial of CABOMETYX tablets in advanced renal cell carcinoma.

Array Biopharma Inc (NASDAQ: ARRY) rose 9.49 percent to $4.15 in pre-market trading after the company reported positive Phase 3 Beacon CRC trial results.

Calavo Growers, Inc. (NASDAQ: CVGW) shares gained 7.97 percent to $60.70 as the company reported stronger-than-expected earnings for its second quarter.